St. Mark's Hospital
Consultant Gastroenterologist at St. Mark''s Hospital
Dr Mani Naghibi gained his medical degree at Guy’s Kings and St Thomas’ School of Medicine in London, where he also undertook a second intercalated degree in Anatomy and Physiology. While at University he carried out research in the topic of drug delivery to the brain. After university he completed his medical training in the London and Wessex deaneries, specialising in Gastroenterology and General Internal Medicine.
Mani undertook his sub-speciality training and research at University Hospital Southampton (UHS), supported by the National Institute of Health Research (NIHR) Biomedical Research Centre for Nutrition. His Medical Doctorate (MD) thesis was based on the use of artificial nutrition for patients with nutrition failure in the context of cancer. He has presented the results of this and other research topics at national and international conferences as well as at invited lectures.
Working with the Inflammatory Bowel Disease team at UHS, Mani was awarded the Shire Prize in innovation in Gastroenterology in 2014 for designing and implementing a web-based patient management system, which allows patients to take greater control of their health and medical treatments.
His clinical interests are supplemental and artificial nutrition, inflammatory bowel conditions, gastrointestinal endoscopy, functional bowel disorders and effects of medical treatments on quality of life. He continues his research interests into the effects of artificial nutrition in both cancer and non-cancer patients.
Before commencing his Consultant post at St Mark’s Hospital, Mani was the Specialist Registrar trainee representative for the British Society of Gastroenterology (BSG) Small Bowel and Nutrition committee, as well as the British Association for Parenteral and Enteral Nutrition (BAPEN). He is currently a committee member for the British Artificial Nutrition Survey (BANS).
Eat your way to prevention, and improved treatment outcomes
Parenteral nutrition uses the intravenous route to maintain fluid and nutrient intake when the use of the gastrointestinal tract has become ineffective or inaccessible. This treatment can be provided at home and used long-term.
If intestinal failure occurs in the context of incurable malignancy the main cause of mortality and morbidity will be dehydration and malnutrition, rather than the direct effects of the underlying malignant process.
This seminar will review the evidence for life expectancy, quality of life, optimal patient selection and the health economics of home parenteral nutrition in this clinical context.
EVEN MORE SEMINARS
Dr Ndaba Mazibuko Care Oncology Clinic, Kings College London
Drug Repurposing In Practice: Metabolic Pleiotropism in Glioblastoma Management
Dr Anita Rose The Raphael Hospital
Cognitive Issues in Multiple Sclerosis
Richard Edwards BSc MBBS FRCS FRCS MD Circle Bath Hospital
Professor of Experimental Medicine
Cheng Boon Worcestershire Royal Hospital
Consultant Clinical Oncologist, GI and Head & Neck